REACH
Phase NA Recruiting
257 enrolled
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
Phase 1 Recruiting
134 enrolled
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Phase 1 Recruiting
51 enrolled
SCOTI
Phase 2 Recruiting
50 enrolled
Optimised Post-discharge Care in Older Patients After Surgery for Colon Cancer (ERAS 3.0)
Phase NA Recruiting
60 enrolled
KANDLELIT-012
Phase 3 Recruiting
477 enrolled
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Phase 3 Recruiting
700 enrolled
PRO-ACTIVE
Recruiting
850 enrolled
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
Recruiting
80 enrolled
AZUR-4
Phase 2 Recruiting
120 enrolled
TRIUNITE-08
Phase 2 Recruiting
106 enrolled
Dual-Target CAR-NK Cells for Biomarker-Selected Advanced Colorectal Cancer
Phase 1/2 Recruiting
48 enrolled
Genomic Services Research Program
Recruiting
5,000 enrolled
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Phase 1 Recruiting
188 enrolled
PILDI
Phase 2 Recruiting
100 enrolled
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
Recruiting
5,000 enrolled
NICHE
Phase 2 Recruiting
353 enrolled
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Phase 1 Recruiting
307 enrolled
Phase II Trial of Lung Chemoemobolization
Phase 2 Recruiting
30 enrolled
BEACON
Recruiting
1,200 enrolled
FORTE
Phase NA Recruiting
9,500 enrolled
CIRCULATE-US
Phase 2/3 Recruiting
1,912 enrolled
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Phase 1 Recruiting
80 enrolled
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Phase NA Recruiting
400 enrolled
A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.
Phase 1 Recruiting
330 enrolled
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
Recruiting
750 enrolled
miR-CIPN#1
Phase NA Recruiting
90 enrolled
Quality Of Life In Colorectal Cancer Survivors
Phase NA Recruiting
368 enrolled
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Recruiting
100 enrolled
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Phase NA Recruiting
360 enrolled
EVEREST-2
Phase 1/2 Recruiting
474 enrolled
A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
Phase 1/2 Recruiting
159 enrolled
Neoadjuvant Therapy With Tislelizumab for dMMR/MSI-H Stage II-III Colorectal Cancer
Recruiting
30 enrolled
UOT WPXRT
Phase NA Recruiting
26 enrolled
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Phase 1 Recruiting
100 enrolled
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Phase 1 Recruiting
170 enrolled
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Phase 1/2 Recruiting
150 enrolled
Superhero
Phase 2 Recruiting
10 enrolled
Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients
Phase NA Recruiting
414 enrolled
Improving Care for Rural Patients With Solid Tumors
Phase NA Recruiting
320 enrolled
PILDI
Phase 2 Recruiting
100 enrolled
ID-COMET
Phase 3 Recruiting
800 enrolled
A Study of PHN-012 in Patients With Advanced Solid Tumors
Phase 1 Recruiting
165 enrolled
AIDPRO-CRC
Phase NA Recruiting
1,200 enrolled
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Phase 3 Recruiting
800 enrolled
COLON-MD
Recruiting
11 enrolled
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Recruiting
500 enrolled
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
Phase 3 Recruiting
892 enrolled
iCaRe2
Recruiting
999,999 enrolled
Strategies for Optimizing a Mailed FIT Program in Appalachia
Phase NA Recruiting
500 enrolled